Use of Botulinum Toxin Injections for the Treatment of Chronic Anal Fissure: Results From an American Society of Colon and Rectal Surgeons Survey
Authors:
- 7 June 2021
- journal article
- research article
- Published by SAGE Publications in The American Surgeon™
- Vol. 89 (3) , 346-354
Abstract
Background: Chronic anal fissure (CAF) is commonly treated by colorectal surgeons. Pharmacological treatment is considered first-line therapy. An alternative treatment modality is chemical sphincterotomy with injection of botulinum toxin (BT). However, there is a lack of a consensus on the BT administration procedure among colorectal surgeons. Methods: A national survey approved by the American Society of Colon and Rectal Surgeons (ASCRS) Executive Council was sent to all members. An eight-question survey was sent via ASCRS email correspondence between December 2019 and February 2020. Questions were derived from available meta-analyses and expert opinions on BT use in CAF patients and included topics such as BT dose, injection technique, and concomitant therapies. The survey was voluntary and anonymous, and all ASCRS members were eligible to complete it. Responses were recorded and analyzed via an online survey platform. Results: 216 ASCRS members responded to the survey and 90% inject 50-100U of BT. Most procedures are performed under MAC anesthesia (56%). A majority of respondents (64%) inject into the internal sphincter and a majority (53%) inject into 4 quadrants in the anal canal circumference. Some respondents perform concomitant manual dilatation (34%) or fissurectomy (38%). Concomitant topical muscle relaxing agents are not used uniformly among respondents. Discussion: Injection of BT for CAF is used commonly by colorectal surgeons. There is consensus on BT dosage, administration site, technique, and the use of monitored anesthesia care.Keywords
This publication has 32 references indexed in Scilit:
- The Role of Botox in Colorectal DisordersCurrent Treatment Options in Gastroenterology, 2018
- Bilateral versus unilateral botulinum toxin injections for chronic anal fissure: a randomised trialTechniques in Coloproctology, 2018
- Botulinum Toxin Injection for Treatment of Chronic Anal Fissure: Is There Any Dose‐Dependent Efficiency? A Meta‐AnalysisWorld Journal of Surgery, 2016
- Anal FissureClinics in Colon and Rectal Surgery, 2016
- Botulinum toxin therapy for chronic anal fissures: where are we at currently?Anz Journal of Surgery, 2015
- Anal FissureClinics in Colon and Rectal Surgery, 2011
- Neuromyogenic properties of the internal anal sphincter: therapeutic rationale for anal fissuresGut, 2000
- Re-examination of clinical manifestations and response to therapy of fissure-in-anoDiseases of the Colon & Rectum, 1997
- The conservative treatment of fissure-in-anoBritish Journal of Surgery, 1983
- Conservative treatment of anal fissureDiseases of the Colon & Rectum, 1978